Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider James Garner acquired 375,000 shares of Percheron Therapeutics stock in a transaction that occurred on Thursday, November 14th. The stock was purchased at an average price of A$0.08 ($0.05) per share, with a total value of A$30,000.00 ($19,480.52).
Percheron Therapeutics Stock Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
See Also
- Five stocks we like better than Percheron Therapeutics
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- What does consumer price index measure?
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
